Telix (TLX) CFO Darren Charlton Smith Buys Shares

What Happened

• Darren Charlton Smith, Chief Financial Officer of Telix Pharmaceuticals Ltd (TLX), acquired 2,071 ordinary shares on September 7, 2026. The reported purchase price was A$9.66 per share for a total reported value of A$19,998. The acquisition was made under the company’s Australian Employee Share Purchase Plan (AU ESPP).

Key Details

• Transaction type: Purchase (code P) via AU ESPP allocation.
• Transaction date: 2026-09-07; Form 4 filed: 2026-09-14 (7 days after the transaction).
• Price and total: A$9.66 per share, total A$19,998 (price and totals recorded in Australian dollars).
• Footnotes: F1 — shares allocated based on Reporting Person’s contributions to the AU ESPP from Jan 1, 2026 to Jun 30, 2026. F2 — purchase price recorded in AUD.
• Shares owned after transaction: Not specified in the provided details.

Context

• This was an ESPP allocation (employee purchase), not an option exercise or sale; such purchases are routine for employee participation in company plans and are typically viewed as direct acquisitions rather than dispositions. The Form 4 filing appears to have been submitted seven days after the transaction date, which is later than the SEC’s usual two-business-day filing requirement for insider transactions.